• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 15th April 2016

OHE Response: The National PROMs Programme Consultation

This post summarises OHE’s response to NHS England’s national PROMs programme consultation. In 2009, the English NHS began collecting patient-reported outcome measures (PROMs) for four elective procedures. Since then, condition specific and generic (EQ-5D) PROMs have been completed by patients…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

This post summarises OHE’s response to NHS England’s national PROMs programme consultation.

In 2009, the English NHS began collecting patient-reported outcome measures (PROMs) for four elective procedures. Since then, condition specific and generic (EQ-5D) PROMs have been completed by patients both before and after these four procedures. PROMs are intended to gather quality of life data from the patient perspective, which can be used to inform decision-making at all levels of the NHS.

In 2010, when the PROMs programme was just underway, we noted (in a joint OHE/King’s Fund publication) that:

“The PROMs initiative is a truly remarkable development for the NHS – and a first internationally: the NHS will be the first health care system in the world to measure what it produces in terms of health, rather than in terms of the production of health care” (Devlin and Appleby, 2010)

Reflecting on the state of play in 2014, we noted:

“So how has this laudable initiative progressed since its initial success? The answer is, sadly, barely at all…the PROMs programme has effectively stalled. The restructuring of the NHS led to responsibility for the PROMs programme shifting from the Department of Health to NHS England…The problem seems to be that, as with many other NHS activities, the 2012 reorganisation led to a loss of focus for the PROMs programme.” (Devlin, Appleby and Parkin, 2014)

In 2006/7, OHE initiated an OHE Commission on NHS Outputs, Productivity and Performance, where we noted:

“A large body of data is available on health care inputs and expenditures; far less is known about the outcomes that the resources and activities produce. Yet, knowing the outcomes achieved by health services is essential to being able to achieve the greatest benefit, and the best patient care, from the resources used. The effectiveness, efficiency and accountability of the NHS all depend on knowing the outcomes it is achieving.” (OHE, 2008)

We continue to hold that view. The NHS PROMs programme represented an important step forward – and deserves the full support of government and the NHS.

NHS England has recently held a consultation on the future of the national PROMs programme, an opportunity which has been welcomed by OHE.

OHE’s key recommendations:

  • The PROMs programme represented a bold, world-leading initiative in 2009. It has the potential to be the centre-piece of an outcomes-led NHS. It deserves strong leadership and a renewed commitment to putting patients’ health outcomes at the heart of health care decision making.
  • More effort should be made to ensure the data are presented in ways that are informative and accessible for the (multiple) decision makers to whom they are relevant: patients; clinicians; providers; commissioners; regulators.
  • The remit of the PROMs programme should be extended beyond the routine collection of PRO data in 4 elective procedures introduced in 2009. ‘Real world’ data from patients should be the cornerstone of a modern health care system.
  • PROMs data are vital to understanding the effectiveness and cost effectiveness of NHS services. For this reason, we strongly urge NHS England to continue to field both a brief, generic PRO questionnaire in combination with a detailed, condition-specific measure, where available. Generic PRO data provide the crucial, common denominator with which to measure outcomes across treatments and diseases.
  • NHS England should strive for excellence in its use of PROs, both in seeking to minimise the costs of data collection (e.g shifting to electronic data capture; considering adopting sampling rather than routine data collection in some cases); and maximising the relevance of the data to the patients providing it; and the impact of the data as a driver of quality improvement.

Access OHE’s full response to the NHS England consultation here.

To learn more about routine measurement of patient outcomes, see:

  • Appleby, J., Devlin, N., Parkin, D. 2016. Using patient reported outcomes to improve health care. Wiley.

Examples of OHE’s PROMs related work:

  • Parkin, D., Feng, Y., Devlin, N. 2016. What Determines the Shape of an EQ-5D Index Distribution? Medical Decision Making (in press)
  • Calvert, M., Thwaites, R., Kyte, D., Devlin, N. 2015 Putting patient-reported outcomes on the ‘Big Data Road Map’ , Journal of the Royal Society of Medicine, 108(8), pp. 299-303.
  • Feng, Y., Pistollato, M., Charlesworth, A., Devlin, N, Propper, C., Sussex, J. 2015. Association between market concentration of hospitals and patient health gain following hip replacement surgery. Journal of Health Services Research and Policy, 20 (1), pp. 11-17.
  • Feng, Y., Parkin, D., Devlin, N. 2014. Assessing the performance of the EQ-VAS in the NHS PROMs programme. Quality of Life Research, 23(3), pp. 977-89.
  • Appleby, J., Poteliakhoff, E., Devlin, N., Shah, K. 2013. Using patient reported outcome measures to estimate cost effectiveness of hip replacements in English hospitals. Journal of the Royal Society of Medicine. 106(8), 323-331.
  • Gutacker, N., Bojke, C., Daidone, S., Devlin, N., Street, A., 2013. Hospital variation in patient-reported outcomes at the level of EQ-5D dimensions: evidence from England. Medical Decision Making, 33(6), pp. 804-818.
  • Nuttall, D., Parkin, D., Devlin, N. 2013. Inter-provider comparisons of patient-reported outcomes: Developing an adjustment to account for differences in patient case mix. Health Economics. 24, 1, pp. 41-54.
  • Barham, L., Devlin, N. 2011. Patient-reported outcome measures: implications for nursing. Nursing Standard, 25(18), pp. 42-5.
  • Gutacker, N., Bojke, C., Daidone, S., Devlin, N., Parkin, D., Street, A. 2011. Truly inefficient or providing better quality of care? Analysing the relationship between risk-adjusted hospital costs and patients’ health outcomes. CHE Research Paper 68. University of York
  • Parkin, D. and Devlin, N. 2011. Using health status to measure NHS performance: Casting light in dark places. BMJ Quality and Safety.
  • Devlin, N. J., Parkin, D. and Browne, J. 2010, Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data. Health Economics, 19, pp. 886–905.

For more information please contact Professor Nancy Devlin at OHE.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • NHS
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!